So how can we educate the people in Medicare who continue to use high risk as a Durie Salmon II-III? They do not take into account the cytogenetics. The current national Medicare ruling only allows coverage of stem cell transplants in first remission for those with a Durie Salmon II-III despite high risk cytogenetics.
So how can we educate the people in Medicare who continue to use high risk as a Durie Salmon II-III? They do not take into account the cytogenetics. The current national Medicare ruling only allows coverage of stem cell transplants in first remission for those with a Durie Salmon II-III despite high risk cytogenetics.